Procalcitonin as a Potential Biomarker in the Study of Babesiosis Caused by B. microti
Abstract
:1. Introduction
2. Methods
3. Results
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Krause, P.J. Human babesiosis. Int. J. Parasitol. 2019, 49, 165–174. [Google Scholar] [CrossRef] [PubMed]
- Homer, M.J.; Aguilar-Delfin, I.; Telford, S.R., III; Krause, P.J.; Persing, D.H. Babesiosis. Clin. Microbiol. Rev. 2000, 13, 451–469. [Google Scholar] [CrossRef] [PubMed]
- Brkljacic, M.; Torti, M.; Pleadin, J.; Mrljak, V.; Smit, I.; Kis, I.; Mayer, I.; Crnogaj, M.; Matijatko, V. The concentrations of the inflammatory markers the amino-terminal portion of C-type pronatriuretic peptide and procalcitonin in canine babesiosis caused by Babesia canis. Veterinarski Arhiv 2014, 84, 575–589. Available online: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiuiaCJtbv0AhVoRTABHbRRBT0QFnoECAIQAQ&url=https%3A%2F%2Fhrcak.srce.hr%2Ffile%2F192425&usg=AovVaw2lnDXXKDkyRtI9MwhhwVzt (accessed on 4 December 2020).
- Häselbarth, K.; Tenter, A.M.; Brade, V.; Krieger, G.; Hunfeld, K.P. First case of human babesiosis in Germany–Clinical presentation and molecular characterization of the pathogen. Int. J. Med. Microbiol. 2007, 297, 197–204. [Google Scholar] [CrossRef] [PubMed]
- Sun, Y.; Li, S.G.; Jiang, J.F.; Wang, X.; Zhang, Y.; Wang, H.; Cao, W.C. Babesia venatorum Infection in Child, China. Emerg. Infect. Dis. 2014, 20, 896–897. [Google Scholar] [CrossRef] [PubMed]
- Guirao-Arrabal, E.; González, L.M.; García-Fogeda, J.L.; Miralles-Adell, C.; Sánchez-Moreno, G.; Chueca, N.; Anguita-Santos, F.; Muñoz-Medina, L.; Vinuesa-García, D.; Hernández-Quero, J.; et al. Imported babesiosis caused by Babesia microti-A case report. Ticks Tick Borne Dis. 2020, 11, 101435. [Google Scholar] [CrossRef] [PubMed]
- Mareedu, N.; Schotthoefer, A.M.; Tompkins, J.; Hall, M.C.; Fritsche, T.R.; Frost, H.M. Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis. Am. J. Trop. Med. Hyg. 2017, 97, 1218–1225. [Google Scholar] [CrossRef] [PubMed]
- Hildebrandt, A.; Zintl, A.; Montero, E.; Hunfeld, K.P.; Gray, J. Human Babesiosis in Europe. Pathogens 2021, 10, 1165. [Google Scholar] [CrossRef] [PubMed]
- White, D.J.; Talarico, J.; Chang, H.; Birkhead, G.S.; Heimberger, T.; Morse, D.L. Human Babesiosis in New York State: Review of 139 Hospitalized Cases and Analysis of Prognostic Factors. Arch. Intern. Med. 1998, 158, 2149–2154. [Google Scholar] [CrossRef] [PubMed]
- Gilbert, D.N. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J. Clin. Microbiol. 2010, 48, 2325–2329. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chiwakata, C.B.; Manegold, C.; Bönicke, L.; Waase, I.; Jülch, C.; Dietrich, M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J. Infect. Dis. 2001, 183, 1161–1164. [Google Scholar] [CrossRef] [PubMed]
- Vijayan, A.L.; Vanimaya; Ravindran, S.; Saikant, R.; Lakshmi, S.; Kartik, R.; Manoj, G. Procalcitonin: A promising diagnostic marker for sepsis and antibiotic therapy. J. Intensive Care 2017, 5, 51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Odeh, M. The role of tumour necrosis factor-alpha in the pathogenesis of complicated falciparum malaria. Cytokine 2001, 14, 11–18. [Google Scholar] [CrossRef] [PubMed]
- Knapp, K.L.; Rice, N.A. Human Coinfection with Borrelia burgdorferi and Babesia microti in the United States. J. Parasitol. Res. 2015, 2015, 587131. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schüttrumpf, S.; Binder, L.; Hagemann, T.; Berkovic, D.; Trümper, L.; Binder, C. Procalcitonin: A useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann. Hematol 2003, 82, 98–103. [Google Scholar] [CrossRef] [PubMed]
- Lee, H. Procalcitonin as a biomarker of infectious diseases. Korean J. Intern. Med. 2013, 28, 285–291. [Google Scholar] [CrossRef] [PubMed]
- Brown, I.; Finnigan, N.A. Fever of Unknown Origin. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2022. [Google Scholar]
- Falagas, M.E.; Klempner, M.S. Babesiosis in Patients with AIDS: A Chronic Infection Presenting as Fever of Unknown Origin. Clin. Infect. Dis. 1996, 22, 809–812. [Google Scholar] [CrossRef] [PubMed]
- Cunha, B.A.; Cohen, Y.Z.; McDermott, B. Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host. Heart Lung 2008, 37, 481–484. [Google Scholar] [CrossRef] [PubMed]
- Bruckner, D.A.; Garcia, L.S.; Shimizu, R.Y.; Goldstein, E.J.; Murray, P.M.; Lazar, G.S. Babesiosis: Problems in diagnosis using autoanalyzers. Am. J. Clin. Pathol. 1985, 83, 520–521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dumas, C.; Tirard-Collet, P.; Mestrallet, F.; Girard, S.; Jallades, L.; Picot, S.; Bienvenu, A.L. Flagging performance of Sysmex XN-10 haematology analyser for malaria detection. J. Clin. Pathol. 2020, 73, 676–677. [Google Scholar] [CrossRef] [PubMed]
Patient Characteristics (Total n = 33) | Number of Cases | % of Cohort |
---|---|---|
Age (years) | ||
40–65 | 14 | 42.4% |
>65 | 19 | 57.6% |
Gender | ||
Male | 21 | 63.6% |
Female | 12 | 36.4% |
Ethnicity: | ||
Caucasian | 19 | 57.6% |
Hispanic | 13 | 39.4% |
Asian | 1 | 3.0% |
Comorbidities | ||
Immunocompromised | 8 | 24.2% |
Splenectomy | 1 | 3.0% |
Hypertension | 13 | 39.4% |
Diabetes | 7 | 21.2% |
Cardiac disease | 8 | 24.2% |
Cancer | 4 | 12.1% |
Chronic kidney disease | 2 | 6.1% |
Chronic lung disease | 6 | 18.2% |
Liver disease | 1 | 3.0% |
Autoimmune disease | 3 | 9.1% |
Admission Status | ||
Inpatient admission | 29 | 87.9% |
ICU admission | 8 | 24.2% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lum, M.; Gauvin, C.; Pham, S.K.; Papamanoli, A.; Spitzer, E.D.; Kalogeropoulos, A.P.; Marcos, L.A. Procalcitonin as a Potential Biomarker in the Study of Babesiosis Caused by B. microti. Pathogens 2022, 11, 1222. https://doi.org/10.3390/pathogens11111222
Lum M, Gauvin C, Pham SK, Papamanoli A, Spitzer ED, Kalogeropoulos AP, Marcos LA. Procalcitonin as a Potential Biomarker in the Study of Babesiosis Caused by B. microti. Pathogens. 2022; 11(11):1222. https://doi.org/10.3390/pathogens11111222
Chicago/Turabian StyleLum, Michael, Caitlin Gauvin, Sophia K. Pham, Aikaterini Papamanoli, Eric D. Spitzer, Andreas P. Kalogeropoulos, and Luis A. Marcos. 2022. "Procalcitonin as a Potential Biomarker in the Study of Babesiosis Caused by B. microti" Pathogens 11, no. 11: 1222. https://doi.org/10.3390/pathogens11111222